The Immune System – News and Features

Inovio will receive $2 million resulting from the filing of a second IND application to the US FDA by Merck for a DNA- vaccine using Inovio's DNA delivery system.

An IND has been filed with the FDA for the fourth Genmab antibody developed under the company's collaboration with Roche.

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.

BioSeek will apply its BioMAP® systems to evaluate a number of UCB compounds across several target classes.

The Company adds promising phase II neurology candidate and receives $8.1 million financing in connection with acquisition.

Both companies will benefit from this new relationship as they have promising activities in the field of new potential antibacterials.

Researchers have discovered that blood stem cells are capable of patrolling the body’s organs where they seek out, and respond to, pathogens.

Green Cross is responsible for the commercialization of ABRAXANE in Korea and will employ an exclusive sales force following regulatory and pricing approval for ABRAXANE.

The work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.

The testing of PLX cells showed a reduction of TNF-a and interferon-? inflammatory cytokines that are involved in the pathogenesis of autoimmune disorders.